Industry News
Blocking melanoma's escape: Avatars break theraping resistance in relapsed cancers
1/08/2016
Melanoma patients who receive treatment with targeted therapies experience an initial response that feels like a cure, but that early excitement is quickly dampened when patients relapse as their...
Epigenetic regulation of metastatic breast cancer progression may guide prognosis and future therapy
1/08/2016
A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for the development of...
Detecting when and why deadly blood clots form
1/08/2016
The Wyss Institute's novel hemostasis monitoring microdevice comprises a microfluidic device with hollow channels through which blood is flowed and a proprietary algorithm for analyzing...
Scientist identifies energy sensor as potential target for cancer drugs
1/08/2016
An international research team formed by a University of Cincinnati (UC) cancer researcher has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP...
OSE Pharma announces initiation of its pivotal Phase 3 trial of Tedopi in non-small cell lung cancer
1/07/2016
OSE Pharma SA, an immunooncology company developing a T-specific immunotherapy for late-stage cancerpatients, has announced the initiation of its registration clinical trial named "Atalante 1".
New role of protein kinases in embryo development and cancer
1/07/2016
A group of protein kinases have been found to play an important role in embryo development and may even be a potential cancer drug target, says research led by Queen Mary University of London...
Published study: Moditope citrullinated peptides stimulate potent anti-tumour responses
1/07/2016
Scancell Holdings Plc, have announced the publication, on line, of a full paper in Cancer Research describing the rationale behind the Company's Moditope® platform and the experimental results...
Published study: Moditope citrullinated peptides stimulate potent anti-tumour responses
1/07/2016
Scancell Holdings Plc, have announced the publication, on line, of a full paper in Cancer Research describing the rationale behind the Company's Moditope® platform and the experimental results...
Could low vitamin D increase the risk of leukemia?
1/07/2016
Researchers found leukemia rates are highest in populations living farther away from the equator, which may be explained by low UVB exposure that leads to low vitamin D levels.
Higher cancer death rate associated with solid-organ transplant recipients
1/07/2016
In solid-organ transplant recipients, the cancer death rate was higher than in the general population in a new study from Ontario, Canada, published online by JAMA Oncology. Nancy N. Baxter, M.D.